Jazz Pharmaceuticals plc — Director's Dealing 2013

May 13, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2013-05-09

Reporting Person: RIEDEL NORBERT G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-09	Ordinary Shares	A	4000	—	Acquired	4000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-09	Nonstatutory Stock Option (right to buy)	$55.28	A	8000	Acquired	2023-05-08	Ordinary Shares (8000)	Direct

Footnotes

F1: These restricted stock units are granted pursuant to the Issuer's 2007 Equity Incentive Plan to the Reporting Person as a non-employee director of the Issuer. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in three equal annual installments on each of the first three anniversaries of May 2, 2013, the date the Reporting Person was first elected to the Issuer's board of directors (the "Vesting Commencement Date").

F2: This option is granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vests over three years from the Vesting Commencement Date, with 1/3 vesting on the first anniversary of the Vesting Commencement Date and the remainder vesting in 24 equal monthly installments thereafter.